| Q47983075 | An immune response profile model for immunogenicity quantitation |
| Q51887243 | Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety. |
| Q37316820 | Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women |
| Q30368524 | Application of DNA microarray technology to influenza A/Vietnam/1194/2004 (H5N1) vaccine safety evaluation. |
| Q86939020 | Computer-Assisted and Data Driven Approaches for Surveillance, Drug Discovery, and Vaccine Design for the Zika Virus |
| Q34119899 | History of vaccination |
| Q42128915 | Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant |
| Q33742218 | Is there a role for a mucosal influenza vaccine in the elderly? |
| Q40932292 | Mucosal vaccines for the prevention of influenza |
| Q30357932 | New vaccines against influenza virus. |
| Q30407716 | Novel vaccines against influenza viruses. |
| Q30381595 | Refining the approach to vaccines against influenza A viruses with pandemic potential. |
| Q64074349 | Role of Multivalency and Antigenic Threshold in Generating Protective Antibody Responses |
| Q36256314 | Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015). |
| Q61910246 | The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales |
| Q30423104 | The impact of influenza A(H1N1)pdm09 infection on immunosuppressed patients |
| Q24197955 | Vaccines for preventing influenza in healthy adults |
| Q24234114 | Vaccines for preventing influenza in healthy adults |
| Q24245429 | Vaccines for preventing influenza in healthy adults |
| Q56603717 | Vaccines for preventing influenza in healthy adults |